ACTINIUM PHARMACEUTICALS, INC. Long-term Debt and Lease Obligation
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Long-term Debt and Lease Obligation of $900.00 thousand as of 2019-12-31, per its 10-K filed 2020-05-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2020-05-08
- 2019-12-31: Long-term Debt and Lease Obligation $900.00K.
- 2019-09-30: Long-term Debt and Lease Obligation $100.00K.
- 2019-06-30: Long-term Debt and Lease Obligation $300.00K.
- 2019-03-31: Long-term Debt and Lease Obligation $200.00K.
| Period end | Long-term Debt and Lease Obligation |
|---|---|
| 2019-12-31 | $900.00K 10-K · filed 2020-05-08 |
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $300.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $200.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |